Goldman Sachs’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Sell |
93,655
-73,384
| -44% | -$388K | ﹤0.01% | 4267 |
|
|
2025
Q1 | $1.36M | Sell |
167,039
-8,440
| -5% | -$68.7K | ﹤0.01% | 3620 |
|
|
2024
Q4 | $2.25M | Buy |
175,479
+90,162
| +106% | +$1.15M | ﹤0.01% | 3394 |
|
|
2024
Q3 | $915K | Sell |
85,317
-8,189
| -9% | -$87.8K | ﹤0.01% | 3805 |
|
|
2024
Q2 | $741K | Buy |
93,506
+12,601
| +16% | +$99.8K | ﹤0.01% | 3744 |
|
|
2024
Q1 | $1.3M | Buy |
80,905
+53,137
| +191% | +$852K | ﹤0.01% | 3458 |
|
|
2023
Q4 | $381K | Buy |
27,768
+5,254
| +23% | +$72.1K | ﹤0.01% | 4072 |
|
|
2023
Q3 | $329K | Sell |
22,514
-10,173
| -31% | -$149K | ﹤0.01% | 4067 |
|
|
2023
Q2 | $556K | Sell |
32,687
-44,108
| -57% | -$750K | ﹤0.01% | 3927 |
|
|
2023
Q1 | $1.07M | Buy |
+76,795
| New | +$1.07M | ﹤0.01% | 3618 |
|
|
2022
Q3 | – | Sell |
-18,273
| Closed | -$87K | – | 5633 |
|
|
2022
Q2 | $87K | Sell |
18,273
-6,718
| -27% | -$32K | ﹤0.01% | 5160 |
|
|
2022
Q1 | $212K | Sell |
24,991
-56,589
| -69% | -$480K | ﹤0.01% | 5065 |
|
|
2021
Q4 | $978K | Buy |
81,580
+71,115
| +680% | +$853K | ﹤0.01% | 4038 |
|
|
2021
Q3 | $185K | Sell |
10,465
-134,608
| -93% | -$2.38M | ﹤0.01% | 4894 |
|
|
2021
Q2 | $2.98M | Buy |
145,073
+46,495
| +47% | +$954K | ﹤0.01% | 3191 |
|
|
2021
Q1 | $1.95M | Buy |
+98,578
| New | +$1.95M | ﹤0.01% | 3397 |
|